We take a proactive and collaborative approach, frequently investing into the companies we also advise. This strategy allows us to actively participate in the decision-making and business development of our investee companies, thereby ensuring we deliver results for our investors. This approach has led to our share price doubling since 2017.

Our recent investments include:

Stabilitech Biopharma

Stabilitech is a biotechnology start-up aiming to disrupt the vaccine market with their thermostable oral vaccine delivery platform, a capsule vaccine that can be delivered by post and simply swallowed – no needles, no queues, and no medical staff. The scope for this technology is enormous and it has the potential to enable cost-effective large scale vaccination programmes in developing countries. Stabilitech was awarded a grant from InnovateUK to successfully develop the world’s first oral Zika vaccine. Using the same patented technology, Stabilitech is now creating an oral Covid-19 vaccine.

Register your Interest

Vulcan Industries Plc

Vulcan is a rapidly expanding manufacturing and precision engineering group of companies. It is soon to complete its fifth acquisition and be listed on the Aquis Stock Exchange (AQSE). It acquires market-leading companies with skilled workforces, and then works to significantly increase their sales and profits by establishing procurement, finance and sales synergies across the group, investing in manufacturing processes and streamlining operations. Their recent successes include M&G Olympic Products, which increased orders to record levels (a 30% increase in annual sales) in its first year since acquisition. 

Vox Markets Group

Vox is an online platform for investors and professionals where they can discover and share content about listed companies. Vox offers digital investor relations services to public companies, allowing them to share news and information with their investment community in a controlled and ethical way.

Partners